AI Centers of Excellence Propel Innovation Forward
Discover how AI Centers of Excellence enhance scalability, security, and innovation at Johnson & Johnson.
- Latest
- Trending
Discover how AI Centers of Excellence enhance scalability, security, and innovation at Johnson & Johnson.
AI in drug discovery market to skyrocket, reaching USD 11,874.24 million by 2032, with a CAGR of 37.5%.
Chinese and US scientists unveil ActFound, an AI model helping optimize drug development by predicting bioactivity efficiently.
Explore top biotech ETFs like XBI, BBH, and IBB, offering potential returns and portfolio diversification in a growing market.
AI tools like those from GE and AWS aim to revolutionize healthcare by unlocking vast amounts of underutilized medical data.
Kezar halts tumor drug trials, pivots to autoimmune hepatitis focus with promising zetomipzomib.
FDA plans to clear numerous AI algorithms, enhancing healthcare through advanced technology regulation and streamlined processes.
Recursion Pharmaceuticals acquires Exscientia to enhance AI drug discovery, potentially saving millions in drug development costs.
Formation Bio secures $372M Series D led by Sanofi to enhance AI-driven drug development, focusing on workflow automation and AI ...
Invest-NL’s Deep Tech Fund injects $26M into Qblox, boosting Dutch ambitions in global quantum technology. The Netherlands eyes leadership in ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.